Palantir is set to release its Q2 on Monday, August 3. Ahead of the release, shares have struggled in recent days, with losses of nearly 10% in the last five. I believe investors should monitor the outlook for commercial bookings for stabilization following a decline in growth seen last quarter.
Shares of Palantir (NASDAQ:PLTR | PLTR Price Prediction) are having quite a rough year, now down 27% year to date.
Wall Street firm Oppenheimer has reiterated its ‘Outperform' rating on Palantir (NASDAQ: PLTR) and maintained a $200 price target.
Software stocks have crashed throughout 2026 as new models from Anthropic and OpenAI flood the market. Recent earnings reports from IBM and ServiceNow fueled further selling in the SaaS landscape.
Palantir Technologies (PLTR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The average of price targets set by Wall Street analysts indicates a potential upside of 56.8% in Palantir Technologies (PLTR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
PLTR's Ontology and AIP Bootcamps are helping enterprises move AI into production, strengthening customer ties and reinforcing long-term growth.
Palantir (NASDAQ:PLTR | PLTR Price Prediction) has been down 29.92% year to date while the S&P 500 has gained 9.60%.
Palantir Technologies Inc. (PLTR) shares fell on Wednesday as investors weighed fresh regulatory scrutiny surrounding the company's UK National Health Service (NHS) Federated Data Platform (FDP) contract alongside growing concerns over emerging competition ahead of its upcoming earnings report. The decline comes as the UK's Office for Statistics Regulation (OSR) addressed concerns over how NHS England presented performance metrics related to the FDP, while investors also assessed reports of a new open-source intelligence tool that mirrors some of Palantir's core capabilities.
Palantir Technologies Inc.'s AIP Bootcamp model creates Ontology-driven customer flywheels, helping U.S. commercial revenue surge 133% year over year in Q1 2026. Remaining Deal Value expanded faster than revenue, showing customers increasingly broaden deployments instead of simply renewing existing software contracts. U.S. government revenue jumped 84% year over year as PLTR became embedded in defense, intelligence and sovereign AI infrastructure across allied nations.
Few stocks in this market have been as polarizing as Palantir (NASDAQ:PLTR | PLTR Price Prediction).